Inovio Pharmaceuticals (INO) Receivables - Other (2010 - 2023)
Inovio Pharmaceuticals (INO) posted Receivables - Other of $5.0 million for Q1 2023, up 8309.83% sequentially from $59000.0 in Q4 2022, and up 42.29% YoY from $3.5 million in Q1 2022.
Inovio Pharmaceuticals (INO) Receivables - Other (2010 - 2023) Analysis & Trends
Inovio Pharmaceuticals has reported Receivables - Other for 14 years, with the latest figure at $5.0 million in Q1 2023.
- Quarterly Receivables - Other rose 42.29% year-over-year to $5.0 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $5.0 million (up 42.29% YoY) and the FY2022 annual result came in at $10.0 million, up 178.79% from the prior year.
- Receivables - Other grew to $5.0 million in Q1 2023 per INO's latest filing, from $59000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $12.9 million in Q2 2021 and troughed at $25000.0 in Q4 2021.
- A 5-year average of $3.7 million and a median of $2.4 million in 2021 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2020 and 2021: Receivables - Other tumbled 89.12% in 2020, then surged 1413.72% in 2021.
- Over 5 years, Receivables - Other stood at $616000.0 in 2019, then sank by 89.12% to $67000.0 in 2020, then plunged by 62.69% to $25000.0 in 2021, then soared by 136.0% to $59000.0 in 2022, then surged by 8309.83% to $5.0 million in 2023.
- According to Business Quant data, Receivables - Other over the past three periods registered $5.0 million, $59000.0, and $7.6 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Inovio Pharmaceuticals | 96.32 Mn | 96.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 4.96 Mn |
| Mar 31, 2023 | 4.96 Mn |
| Dec 31, 2022 | 59,000.00 |
| Dec 31, 2022 | 59,000.00 |
| Sep 30, 2022 | 7.64 Mn |
| Sep 30, 2022 | 7.64 Mn |
| Jun 30, 2022 | 6.89 Mn |
| Jun 30, 2022 | 6.89 Mn |
| Mar 31, 2022 | 3.49 Mn |
| Mar 31, 2022 | 3.49 Mn |
| Dec 31, 2021 | 25,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Sep 30, 2021 | 2.35 Mn |
| Sep 30, 2021 | 2.35 Mn |
| Jun 30, 2021 | 12.90 Mn |
| Jun 30, 2021 | 12.90 Mn |
| Mar 31, 2021 | 9.60 Mn |
| Mar 31, 2021 | 9.60 Mn |
| Dec 31, 2020 | 67,000.00 |
| Dec 31, 2020 | 67,000.00 |